While non- aggressive human BCC subtypes display high NEO1 expression, aggressive human BCC subtypes present with lower levels of NEO1, similar to GLI1, suggesting a possible role of SHH/GLI/NEO1 signaling in tumor aggressiveness. The gene discussed is NEO1; the disease is skin basal cell carcinoma.